Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$600K Hold
16,350
0.07% 212
2017
Q2
$742K Buy
16,350
+400
+3% +$17.7K 0.1% 182
2017
Q1
$679K Buy
15,950
+1,000
+7% +$40.8K 0.09% 187
2016
Q4
$600K Hold
14,950
0.09% 197
2016
Q3
$581K Sell
14,950
-1,000
-6% -$37.8K 0.09% 190
2016
Q2
$552K Buy
15,950
+9,250
+138% +$320K 0.09% 190
2016
Q1
$231K Hold
6,700
0.04% 274
2015
Q4
$259K Hold
6,700
0.04% 250
2015
Q3
$262K Hold
6,700
0.04% 249
2015
Q2
$255K Hold
6,700
0.04% 276
2015
Q1
$221K Buy
+6,700
New +$206K 0.03% 286

Other funds holding HOLX

Gerald L. Ray & Associates's HOLX Position: Q3 2017 in Review

Gerald L. Ray & Associates held its Hologic (HOLX) position steady in Q3 2017 at 16,350 shares worth $600K. The position accounts for 0.07% of the portfolio, ranked #212.

Gerald L. Ray & Associates first reported a position in HOLX in Q1 2015 and has held it in 11 quarters since. The position peaked at $742K in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Gerald L. Ray & Associates held 16,350 shares of Hologic worth $600K as of Q3 2017.
  • Gerald L. Ray & Associates left its Hologic share count unchanged in Q3 2017.
  • Hologic made up 0.07% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #212 holding.
  • Gerald L. Ray & Associates first reported a position in Hologic in Q1 2015 and has held it in 11 quarters since.
  • Gerald L. Ray & Associates's Hologic position peaked at $742K in Q2 2017.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.